What were the results of the meta-analysis of cardiovas- cular outcomes trials comparing intensive versus moderate statin therapy?
The meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy showed that intensive statin therapy was associated with a lower risk of death from all causes, myocardial infarction, and stroke compared to moderate statin therapy. The meta-analysis also showed that the benefit of intensive statin therapy was most pronounced in patients with diabetes and those with a history of cardiovascular disease. Additionally, the meta-analysis showed that intensive statin therapy was associated with a small increase in the risk of side effects such as muscle pain. However, the risk was found to be small and outweighed by the benefits of intensive statin therapy. 